Science based company Unicity, which launched world’s first ever Genomeceutical (gene controlling) range of products “Neigene” in the country, has plans to launch several more products in the next 2-3 years.
The company is also hoping to set up a production unit in future as most of the products of unicity are manufactured in india only through contract manufacturers.
“Beautiful skin starts with healthy cells. Neigene is designed using advanced, cell-targeted, healthy-aging technology. We have pioneered this as our first Genomeceutical(gene controlling) product. Research is underway to apply this technology to other areas of body care,” said Unicity Chief Scientific Officer Dr Dan Gubler
The company launched its operations in India on 2010 and now with the launch of world’s first ever Genomeceuticals product range, it aims to create a premium and inimitable forte for itself in the personal care market.
With a US patent of Unicity’s Gene expression controlling technology in their artillery. Genomeceutical is a ground-breaking, patent-pending, technology whereby certain secondary metabolites found in nature can help maintain the gene response whenever needed by the body and help maintain overall metabolic health of the body by tapping into the nutrient-sensing pathways of genes.
The company has a roaster of 16 products already registered in the benchmark Physicians’ Desk Reference (PDR). Recognized as one of the Top 500 privately-held businesses in the United States, and ranked 87th on the national level and first in the state of Utah (US), Unicity stands as an industry leader for both nutritional supplements and an extensive global distribution network. Unicity comes with previous successfully estalished products like Matcha Tea and Bios life Slim.